Lepu Medical to Host Live Online Launch Event for Peripheral Product Portfolio – Artery New Product Review Episode 112

According to data released by VCBeat in 2024, the number of surgical procedures for lower extremity arterial disease reached 65,000 cases in 2023. The volume of vascular surgeries has been increasing year by year, with endovascular techniques developing at a relatively faster pace, indicating broad market prospects for peripheral interventions.

September 29, 2024Lepu Medical Technology (Beijing) Co., Ltd.(hereinafter referred to as “Lepu Medical”) developed“ThorCrack” for Pre-treatment of Peripheral Vascular Calcified Lesions^®"Single-Use Peripheral Intravascular Shockwave Catheter"Received registration approval for market launch from the National Medical Products Administration (NMPA) (National Medical Device Registration No. 20243011933); on October 17, its developed“ANGIOCIDE II” for Preconditioning in Peripheral Vascular Disease^™Peripheral Cutting Balloon CatheterIt has also successfully obtained the NMPA Class III Medical Device Registration Certificate (National Medical Device Registration No. 20243032050).

Following the successive launches of products such as peripheral shockwave balloons and peripheral cutting balloons, Lepu Medical’s peripheral product portfolio has become increasingly comprehensive.Shifting from a previous focus on cardiovascular interventions to a dual-track development in both cardiovascular and peripheral vascular interventions.

On Monday, November 11, at 19:30, the 112th session of VCBeat New Product Review will feature Zhou Weihang, Academic Supervisor of the Marketing Department at Lepu Medical, and Zhang Hao, Academic Supervisor of the Marketing Department at Lepu Medical.“Lepu Medical Peripheral Series”Product Introduction.

Product 1: ThorCrack^®Disposable Peripheral Intravascular Shockwave Catheter (National Medical Device Registration No. 20243011933)

Product 2: ANGIOCIDEⅡ^™Peripheral Cutting Balloon Catheter (National Medical Device Registration No. 20243032050)

Product 1: ThorCrack^®Disposable Intravascular Shockwave Catheter for Peripheral Vessels

The launch of this product will further enrich Lepu’s peripheral vascular product portfolio, providing a brand-new option for the pretreatment of calcified lesions in clinical practice!

● Parallel Electrode Arrangement:

Redundant design with four pairs of electrodes arranged in parallel for more stable discharge and effective fragmentation of calcification.

● Uniform Energy Distribution:

Wide Shockwave Energy Dispersion Range - More Effective

Virtually No Damage to Normal Vascular Tissue – Safer

● Intelligent Device Display:

Intelligent Reminders,High-definition large screen with ultra-wide viewing angle interface; prompts for catheter connection upon startup; intelligent identification of catheter model

Personalized ringtones,The device emits an audible alert during operation, precisely indicating the number of discharge cycles.

Ultra-long battery life,Large built-in battery capacity (16,000mAh); low power consumption per discharge during operation, resulting in greater energy efficiency

Comprehensive Interface Display,Precisely displays pulse cycle counts, remaining cycles, and other information to assist operators in accurately assessing lesion pre-treatment status.

Product 2: ANGIOCIDEⅡ™ Peripheral Cutting Balloon Catheter

As Lepu Medical’s new-generation cutting balloon, it delivers superior performance and a more comprehensive range of specifications and models, providing thorough and meticulous support for the precise recanalization and effective treatment of target lesions.

● Exceptional Scalability:

Precision alloy steel blades enable the cutting balloon to effectively dilate various lesions, including calcified ones. The arrangement of four columns and four rows of blades also delivers more uniform and efficient dilation.

● Safe Working Height:

The blade height is only 0.13 mm, significantly lower than that of other functional balloon products, enabling precise cutting and compression of plaques while minimizing impact on normal tissue, thereby avoiding risks such as vascular perforation at the source.

● Excellent Passability:

The eight-wing folding method and T-slot blade design significantly enhance the crossing capability of the cutting balloon, while the specialized shaping process provides operational flexibility for the balloon’s repeated use.

● Complete Range of Specifications and Models:

Covers diameters from 2.0 to 8.0 mm, compatible with 0.018" guidewire systems, fully meeting the clinical needs of peripheral vascular procedures.

Scan the QR code on the poster to add the assistant and schedule the live broadcast.

Zhou Weihang
Academic Supervisor, Marketing Department, Lepu Medical

Primarily responsible for providing academic support, conducting marketing activities, and organizing conferences for Lepu Medical’s coronary product line, including bioresorbable scaffolds, drug-coated balloons, cutting balloons, and intravascular lithotripsy balloons; also responsible for product promotion across all provinces in China.

Zhang Hao
Academic Supervisor, Marketing Department, Lepu Medical

Primarily responsible for academic support, marketing, and conference organization for Lepu Medical’s peripheral product line, including shockwave balloons, cutting balloons, vascular sheaths, and infusion systems, as well as overseeing product promotion across all provinces in China.

Lepu Medical Technology (Beijing) Co., Ltd. (hereinafter referred to as “Lepu Medical”) was founded in 1999. It is one of the earliest enterprises in China engaged in the research, development, and manufacturing of cardiovascular interventional medical devices, and among the few domestic companies capable of competing strongly with foreign products in the high-end medical device sector. Lepu Medical is committed to building a platform enterprise for the research, development, production, and sales of pan-cardiovascular products. Its current core business spans three major segments: medical devices, pharmaceuticals, and healthcare services & health management, with medical devices serving as its core business.

Lepu Medical is primarily engaged in the R&D and manufacturing of high-end innovative medical devices, including cardiovascular stents, pacemakers, and heart valves, establishing itself as a pioneer and leader in China’s implantable medical device industry. Lepu Medical was the first company in China to obtain registration certificates for both metallic stents and bioresorbable stents, the first globally to secure regulatory approval for a fully bioresorbable occluder, the first domestic manufacturer of cardiac pacemakers, the first heart valve manufacturer in Asia, and the first enterprise in China to industrialize AI-based medical technologies.

“VCBeat New Product Showcase” is a live-streaming series dedicated to supporting healthcare companies in launching their innovative products. The program’s mission is to empower the milestone launch of every medical innovation. If your company has plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “VCBeat New Product Showcase,” please add our assistant for inquiries.

Scan the QR code below to contact the assistant and schedule a live stream (if you have already added them, please reach out to the assistant directly).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Contact the assistant to send a screenshot of the live stream and participate in the lucky draw for a chance to win a [15-day trial membership of VBInsight].